Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring.

[1]  Hyesung Jeon,et al.  Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Ick Chan Kwon,et al.  Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Kwangmeyung Kim,et al.  Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Robert Langer,et al.  Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers , 2008, Proceedings of the National Academy of Sciences.

[5]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[6]  Ick Chan Kwon,et al.  Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[7]  M. Tsuang,et al.  Shifting emphasis from pharmacogenomics to theragnostics , 2006, Nature Biotechnology.

[8]  R. Weissleder.  Molecular Imaging in Cancer , 2006, Science.

[9]  Ick Chan Kwon,et al.  Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[10]  H. Yoo,et al.  Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[11]  H. Ueno,et al.  Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin , 2004, British Journal of Cancer.

[12]  Ick Chan Kwon,et al.  Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[13]  H. Gelderblom,et al.  Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens , 2004, British Journal of Cancer.

[14]  I. Kwon,et al.  Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[15]  I. Kwon,et al.  Synthesis and characterization of sugar-bearing chitosan derivatives: aqueous solubility and biodegradability. , 2003, Biomacromolecules.

[16]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[17]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[18]  H. S. Oh,et al.  In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[19]  G. Barratt,et al.  Therapeutic applications of colloidal drug carriers. , 2000, Pharmaceutical science & technology today.

[20]  E. Ruoslahti,et al.  Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.

[21]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[23]  Jinwoo Cheon,et al.  Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging , 2007, Nature Medicine.

[24]  Ick Chan Kwon,et al.  Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. , 2006, Biomaterials.